23andMe Rakes in $79 Million As It Looks to Develop Own Drug Pipeline
Gilead (GILD) Bets $125 Million on Spurring Investigational HIV Drug to Market
Allergan (AGN) Slams Down $250 Million+ for Rights to Merck & Co. (MRK)'s Migraine Drugs
Horizon Pharma (HZNP) Goes Hostile With $3 Billion Bid for Depomed (DEPO)
Teva (TEVA) Will Up New Mylan (MYL) Bid to $43 Billion: Report
FDA Bestows Breakthrough Therapy Designation on Dyax Corp. (DYAX)'s HAE Drug As Suitors Circle
IMPAX Labs (IPXL) Founder and Ex-CEO Resigns Board Seat
EXCLUSIVE: New Report Says Biosimilars Will Earn $55B by 2020, As Pfizer (PFE), Actavis (ACT), AbbVie (ABBV) Claim U.S. Market
EXCLUSIVE: DNAnexus, Inc., Stanford University Genomic Catalog Will Accelerate Science in the Field, Says CEO
Ex-Pharmacyclics (PCYC) CEO Banks $33.5 Million for Startup Corvus Pharma
Vertex (VRTX) Gets FDA Approval for $259K Per Year CF Drug
Allergan (AGN) Forks Over $125 Million+ for Bay Area Medtech Firm Oculeve
Celgene (CELG) Snaps Up Merck & Co. (MRK)'s Giant Complex in New Jersey
Pfizer (PFE)'s Champix Linked to Terminated Health Care Workers in British Columbia: Report
Novo Nordisk A/S (NVO) Terminates GLP-1 Patch Deal with Zosano
Johnson & Johnson (JNJ) HIV Vaccine Blocks Virus in 50% of Monkeys, Soon to Start Human Trial in 400
GlaxoSmithKline (GSK) Will Receive $140B+ Bid in Q4, From Suitors Including Pfizer (PFE) and AstraZeneca PLC (AZN): Poll
Genentech (RHHBY)'s Ocrelizumab Wows in Late Stages and Eyes $18 Billion MS Market
See All News >
//-->